Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2025 年第 1 季持倉
持倉截至 2025/3/31，2025/5/15 申報。只含多頭部位，變化是跟 2024 年第 4 季比股數。
- 持股檔數
- 69
- 較 2024 年第 4 季 +8
- 總值
- $30.9 億
- 較 2024 年第 4 季 +$4.21 億 (+15.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,000,000 | $2.64 億 | 8.5% | 00.0% | 不變 | 歷史 |
| GHGuardant Health, Inc. | COM | 5,443,721 | $2.32 億 | 7.5% | −975,845−15.2% | 減碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 17,791,486 | $2.31 億 | 7.5% | 00.0% | 不變 | 歷史 |
| IMVTImmunovant, Inc. | COM | 9,500,000 | $1.62 億 | 5.3% | +3,500,000+58.3% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 3,000,000 | $1.45 億 | 4.7% | +2,000,000+200.0% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 4,564,207 | $1.38 億 | 4.5% | +2,630,279+136.0% | 加碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 3,210,270 | $1.30 億 | 4.2% | +1,720,270+115.5% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 3,073,853 | $1.24 億 | 4.0% | +573,853+23.0% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 5,000,000 | $1.09 億 | 3.5% | +725,079+17.0% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 14,294,420 | $1.05 億 | 3.4% | +1,458,138+11.4% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 2,800,000 | $9,680 萬 | 3.1% | +1,980,838+241.8% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,484,266 | $7,625 萬 | 2.5% | +1,484,266 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 5,380,449 | $7,253 萬 | 2.3% | +857,708+19.0% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 4,100,000 | $7,097 萬 | 2.3% | +1,300,000+46.4% | 加碼 | 歷史 |
| ETNB89bio, Inc. | COM | 9,316,333 | $6,773 萬 | 2.2% | +2,838,084+43.8% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 5,500,000 | $6,534 萬 | 2.1% | +2,500,000+83.3% | 加碼 | 歷史 |
| GERNGeron Corp | COM | 38,176,251 | $6,070 萬 | 2.0% | +34,164,964+851.7% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 899,731 | $5,742 萬 | 1.9% | +899,731 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 1,350,000 | $4,888 萬 | 1.6% | +696,487+106.6% | 加碼 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 700,000 | $4,687 萬 | 1.5% | +50,958+7.9% | 加碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 2,357,702 | $4,277 萬 | 1.4% | +2,357,702 | 新進 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 1,411,402 | $4,188 萬 | 1.4% | +892,026+171.7% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 2,000,000 | $3,630 萬 | 1.2% | +459,868+29.9% | 加碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 3,269,126 | $3,599 萬 | 1.2% | +3,269,126 | 新進 | 歷史 |
| AMGNAmgen Inc | Stock | 113,035 | $3,522 萬 | 1.1% | +113,035 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,000,000 | $3,355 萬 | 1.1% | +830,868+491.3% | 加碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,400,000 | $3,080 萬 | 1.0% | +689,579+97.1% | 加碼 | 歷史 |
| MTSRMetsera, Inc. | COM | 1,094,408 | $2,979 萬 | 1.0% | +1,094,408 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 750,000 | $2,832 萬 | 0.9% | +750,000 | 新進 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 17,849,482 | $2,767 萬 | 0.9% | +3,630,579+25.5% | 加碼 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 2,000,000 | $2,606 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 8,859,648 | $2,534 萬 | 0.8% | +8,859,648 | 新進 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 1,401,938 | $2,483 萬 | 0.8% | +1,401,938 | 新進 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 3,579,209 | $2,237 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 3,018,935 | $2,228 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 2,000,000 | $2,206 萬 | 0.7% | +2,000,000 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,000,000 | $2,092 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 4,557,575 | $2,042 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 254,751 | $1,943 萬 | 0.6% | +254,751 | 新進 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 741,068 | $1,862 萬 | 0.6% | −39,710−5.1% | 減碼 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 2,038,845 | $1,621 萬 | 0.5% | +2,038,845 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 5,576,558 | $1,539 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| KRROKorro Bio, Inc. | COM | 874,614 | $1,523 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 1,444,709 | $1,482 萬 | 0.5% | +694,709+92.6% | 加碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 2,500,000 | $1,463 萬 | 0.5% | −316,594−11.2% | 減碼 | 歷史 |
| UPBUpstream Bio, Inc. | COM | 2,299,567 | $1,407 萬 | 0.5% | +1,299,567+130.0% | 加碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,442,833 | $1,295 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| SEPNSepterna, Inc. | COM | 1,912,929 | $1,108 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NVAXNovavax Inc | COM NEW | 1,518,182 | $973.2 萬 | 0.3% | −481,818−24.1% | 減碼 | 歷史 |
| HELPCybin Inc. | COM NEW | 1,529,987 | $970.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 6,011,380 | $733.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 5,399,681 | $729.0 萬 | 0.2% | −572,576−9.6% | 減碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 859,876 | $688.8 萬 | 0.2% | −7,124−0.8% | 減碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 767,016 | $651.2 萬 | 0.2% | −509,065−39.9% | 減碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 315,765 | $616.7 萬 | 0.2% | +315,765 | 新進 | 歷史 |
| IVVDInvivyd, Inc. | COM | 9,722,254 | $588.5 萬 | 0.2% | −967,349−9.0% | 減碼 | 歷史 |
| XNCRXencor Inc | COM | 549,439 | $584.6 萬 | 0.2% | +49,439+9.9% | 加碼 | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 3,262,564 | $570.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 3,119,162 | $508.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 457,556 | $458.9 萬 | 0.1% | +457,556 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $454.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 3,283,783 | $423.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM NEW | 444,110 | $366.4 萬 | 0.1% | +200,000+81.9% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 219,015 | $353.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IMAImageneBio, Inc. | COM | 2,515,513 | $322.0 萬 | 0.1% | +2,515,513 | 新進 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 523,989 | $225.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALLKAllakos Inc. | COM | 7,232,701 | $164.6 萬 | 0.1% | +1,528,419+26.8% | 加碼 | 歷史 |
| NGNENeurogene Inc. | COM | 116,660 | $136.6 萬 | <0.1% | +116,660 | 新進 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,040,115 | $126.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
2024 年第 4 季之後清倉（8 檔）
2024 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 4 季股數 | 2024 年第 4 季市值 | 2024 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,460,756 | $1.25 億 | 4.7% | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,450,000 | $4,989 萬 | 1.9% | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 4,000,000 | $4,240 萬 | 1.6% | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 2,000,000 | $4,174 萬 | 1.6% | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 850,000 | $3,947 萬 | 1.5% | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,350,000 | $2,261 萬 | 0.8% | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 609,900 | $339.7 萬 | 0.1% | 歷史 |
| NKTRNektar Therapeutics | COM | 1,975,998 | $183.8 萬 | 0.1% | 歷史 |